Genetron health (Beijing) Co., Ltd

Genetron Health is a leading and fast-growing precision oncology company in China that aims to provide one-stop genomic profiling solutions for multiple scenarios covering early screening, diagnosis and monitoring, and biopharmaceutical services. The company collaborates with over 400 hospitals and dozens of biopharmaceutical companies and research institutions and has developed a large proprietary genomic database. On diagnosis and monitoring, the company provides comprehensive diagnostic services and products that cover eight out of the top ten major cancer types in China using tissue or liquid biopsy samples. Leveraging patented technologies including Genetron One-Step Seq Method, the company has developed a comprehensive IVD product portfolio across NGS, dPCR and qPCR, including seven NMPA approved sequencing platforms and gene assays suitable for clinical application in China. On the frontier of early screening, the company has developed Mutation Capsule technology to detect genomic mutations and methylation alterations in one reaction. The Company has launched a prospective study cohort for liver cancer early screening and was approved to join several China National Key Research and Development Project for early screening in liver cancer, lung cancer and digestive cancer On development services, the company collaborates with dozens of biopharmaceutical companies, hospitals and research institutions both in China and globally to serve their needs in genomics research and clinical development covering biomarker evaluation for molecularly targeted therapy and immuno-therapy, clinical trial enrollment, companion diagnostics development and joint marketing post-drug approval. Genetron Health has established R&D centers in both the United States and China, two manufacturing facilities with both ISO 13485:2016 certification and ISO 9001:2015 certification in China and five clinical laboratories in Beijing (CLIA accreditation and CAP certification), Shanghai, Hangzhou, Chongqing and Guangzhou. The R&D capacities of Genetron Health are supported by a best-in-class research and development team led by scientists at the forefront of cancer genomics research. The company has published many research papers in highly influential worldwide peer-reviewed scientific journals, such as Nature Genetics, Nature Communications, Cell Research and PNAS.